Comparison in patients with type 2 diabetes of fibric acid versus HMG-CoA reductase inhibitor treatment of combined dyslipidemia

被引：0
|
作者：
McLaughlin, TL
Abbasi, F
Lamendola, CA
Leary, E
Reaven, GM
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2036
引用
收藏
页码：A495 / A496
页数：2
相关论文
共 50 条
  • [31] Geographic Variation in HMG-CoA Reductase Inhibitor Use in Dialysis Patients
    James B. Wetmore
    Jonathan D. Mahnken
    Purna Mukhopadhyay
    Qingjiang Hou
    Edward F. Ellerbeck
    Sally K. Rigler
    John A. Spertus
    Theresa I. Shireman
    Journal of General Internal Medicine, 2012, 27 : 1475 - 1483
  • [32] Pharmaco-economic impact of HMG-CoA reductase inhibitors in type 2 diabetes
    Chaiyakunapruk, N
    Boudreau, D
    Ramsey, SD
    JOURNAL OF CARDIOVASCULAR RISK, 2001, 8 (03): : 127 - 132
  • [33] EFFECTS OF HMG-COA REDUCTASE INHIBITOR (LOVASTATIN) IN HYPERCHOLESTEROLEMIC PATIENTS ON DIALYSIS
    VILLORIA, JG
    MOLINA, HD
    LOPEZ, AG
    KIDNEY INTERNATIONAL, 1993, 44 (06) : 1453 - 1454
  • [34] Geographic Variation in HMG-CoA Reductase Inhibitor Use in Dialysis Patients
    Wetmore, James B.
    Mahnken, Jonathan D.
    Mukhopadhyay, Purna
    Hou, Qingjiang
    Ellerbeck, Edward F.
    Rigler, Sally K.
    Spertus, John A.
    Shireman, Theresa I.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 (11) : 1475 - 1483
  • [35] The effect of HMG-CoA reductase inhibitor on glucose tolerance and insulin sensitivity in type 2 diabetes mellitus animal model
    Kwon, Hyuk-Sang
    Hong, Oak-Kee
    Ko, Seung-Hyun
    Choi, Yoon-Hee
    Lee, Sung-Soo
    Son, Tae-Seo
    Moon, Sung-Dae
    Yoo, Soon-Jib
    Son, Hyun-Sik
    Yoon, Kun-Ho
    Cha, Bong-Yun
    Son, Ho-Young
    DIABETES, 2006, 55 : A565 - A565
  • [36] Effect of Eicosapentaic Acid and HMG-CoA Reductase Inhibitor on Chronic Heart Failure
    Node, Koichi
    Kotooka, Norihiko
    Oyama, Jun-Ichi
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S139 - S139
  • [37] The effect of HMG-CoA reductase inhibitor on glucose tolerance and insulin sensitivity in type 2 diabetes mellitus animal model
    Kwon, H. -S.
    Hong, O. -K.
    Ko, S. -H.
    Choi, Y. -H.
    Lee, S. -S.
    Son, T. -S.
    Moon, S. -D.
    Yoo, S. -J.
    Son, H. -S.
    Yoon, K. -H.
    Cha, B. -Y.
    Son, H. -Y.
    DIABETOLOGIA, 2006, 49 : 370 - 370
  • [38] HMG-CoA reductase inhibitor, simvastatin improves reverse cholesterol transport in type 2 diabetic patients with hyperlipidemia
    Guan, Jing-Zhi
    Tamasawa, Naoki
    Murakami, Hiroshi
    Matsui, Jun
    Tanabe, Jutaro
    Matsuki, Kota
    Yamashita, Maki
    Suda, Toshihiro
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2008, 15 (01) : 20 - 25
  • [39] Effect of eicosapentaenoic acid in combination with HMG-CoA reductase inhibitor on lipid metabolism
    Mataki, H
    Watuji, K
    Miwa, S
    Matsushita, K
    Miki, T
    Go, M
    Ishida, K
    Okada, S
    Yokoyama, M
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 129 - 129
  • [40] Chronic creatine kinase elevation not associated with HMG-CoA reductase inhibitor treatment
    Lin, JC
    Ito, MK
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (02) : 163 - 166
12345